Please try another search
CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Harry Kim | - | 2019 | Special Advisor |
Craig R. Cooper | 60 | 2017 | Co-Founder, Group CEO, MD & Executive Director |
John Cockcroft | - | 2022 | Member of Medical Advisory Board |
Alberto Avolio | - | - | Member of Medical Advisory Board |
Niall Charles Edgar Cairns | 59 | 2017 | Co-Founder & Executive Chairman |
Randall King Nelson | 66 | 2015 | Independent Non-Executive Director |
Charlie Taylor | - | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review